NORTH AMERICA BIOSURGERY MARKET 2019-2027

MARKET OUTLOOK
The North America biosurgery market is expected to develop at a CAGR of 7.68% during the forecasting period of 2019-2027.
The biosurgery market in North America includes the countries of the United States and Canada.
North America generates the largest revenue, representing nearly 41% of the market for biosurgery. Factors such as an aging population; growth in the occurrence and pervasiveness of chronic diseases, specifically carcinogenic and cardiovascular diseases; expeditious acceptance of advancements in technology; and the increased funding & investments from the governments contribute to the market growth in this region. However, stringent rules and regulations are expected to restrain the growth of the market during the forecast period.
By region, North America holds the highest market share in the biosurgery market. It includes the U.S. and Canada. In addition to increasing rates of cardiovascular disease and cancer, increasing rates of other chronic diseases such as hernia, neurologic and spinal disorders, and gynecological and orthopedic problems provide several opportunities in North America for various types of biological products.
COMPETITIVE OUTLOOK
The top players exhibiting the biosurgery market are Medtronic Plc, Smith & Nephew Plc, Sanofi, Wright Medical Group N.V., Zimmer Biomet Holdings, Inc., Baxter International, Inc., Olympus Corporation, RTI Surgical, B. Braun Melsungen AG, Stryker Corporation, Johnson & Johnson, Ypsomed Holding AG and Ethicon, Inc.

TABLE OF CONTENTS
1. BIOSURGERY MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. TRENDS IN BIOSURGERY TECHNOLOGY
2.3. REGULATORY FRAMEWORK
2.4. KEY VENDORS OUTLOOK
2.5. KEY INSIGHTS
2.6. KEY BUYING OUTLOOK
2.7. KEY PATENT OUTLOOK
2.8. MARKET DRIVERS
2.8.1. RISE IN SURGICAL TREATMENTS FOR MUSCULOSKELETAL DISORDERS
2.8.2. RISE IN SPINAL FUSION AND JOINT RECONSTRUCTION
2.8.3. INCREASING TRAUMA-RELATED WOUNDS
2.9. MARKET RESTRAINTS
2.9.1. STRINGENT REGULATORY APPROVAL
2.9.2. INCREASE IN THE COST OF SURGERIES
2.9.3. INCREASING USAGE OF MINIMALLY INVASIVE SURGERIES
2.9.4. LACK OF AWARENESS
2.10. MARKET OPPORTUNITIES
2.10.1. DEVELOPMENT OF POLICY FOR REIMBURSEMENT AND COMPENSATION
2.10.2. INCREASE IN RESEARCH AND INVESTMENT IN BIOENGINEERING
2.11. MARKET CHALLENGES
2.11.1. AMPLIFIED SCRUTINY OF STEM CELL-DERIVED PRODUCTS
2.11.2. COMPLICATION RELATED TO IMMUNE RESPONSE
2.11.3. LACK OF SIGNIFICANT DIFFERENTIATION IN THE RANGE OF PRODUCTS
2.11.4. PRODUCT SIDE-EFFECTS AND FDA INQUIRY
3. BIOSURGERY MARKET OUTLOOK - BY PRODUCT
3.1. BONE-GRAFT SUBSTITUTES
3.1.1. SYNTHETIC GRAFT EXTENDER
3.1.2. DEMINERALIZED BONE MATRIX
3.1.3. BONE MORPHOGENETIC PROTEINS
3.1.4. CELL-BASED MATRICES
3.2. HEMOSTATIC AGENTS
3.3. SOFT-TISSUE MANAGEMENT
3.3.1. SYNTHETIC MESH/PATCH
3.3.2. NATURAL MESH/PATCH
3.4. SURGICAL SEALING AGENTS
3.4.1. NATURAL SURGICAL SEALING AGENTS
3.4.2. SYNTHETIC SURGICAL SEALING AGENTS
3.5. ANTI-ADHESIVE AGENTS
4. BIOSURGERY MARKET OUTLOOK - BY APPLICATION
4.1. NEURO AND SPINE SURGERY
4.2. CARDIO AND THORACIC SURGERY
4.3. GENERAL SURGERY
4.4. ORTHOPEDIC SURGERY
5. BIOSURGERY MARKET OUTLOOK - BY SOURCE TYPE
5.1. NATURAL
5.2. SYNTHETIC
6. BIOSURGERY MARKET - REGIONAL OUTLOOK
6.1. NORTH AMERICA
6.1.1. COUNTRY ANALYSIS
6.1.1.1. THE UNITED STATES
6.1.1.2. CANADA
7. COMPETITIVE LANDSCAPE
7.1. B. BRAUN MELSUNGEN AG
7.2. JOHNSON & JOHNSON
7.3. BAXTER INTERNATIONAL, INC.
7.4. ETHICON, INC.
7.5. MEDTRONIC PLC
7.6. SANOFI
7.7. OLYMPUS CORPORATION
7.8. RTI SURGICAL
7.9. SMITH & NEPHEW PLC
7.10. STRYKER CORPORATION
7.11. ZIMMER BIOMET HOLDINGS, INC.
7.12. WRIGHT MEDICAL GROUP N.V.
7.13. YPSOMED HOLDING AG
8. METHODOLOGY AND SCOPE
8.1. RESEARCH SCOPE
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY


TABLE LIST
TABLE 1 NORTH AMERICA BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
TABLE 2 MEDICAL DEVICE CLASSIFICATION
TABLE 3 TYPES OF PMA SUPPLEMENTS
TABLE 4 MEDICAL DEVICES BY CLASS
TABLE 5 NORTH AMERICA BIOSURGERY MARKET BY PRODUCTS 2019-2027 (IN $ MILLION)
TABLE 6 DIFFERENT TYPES OF BONE-GRAFT SUBSTITUTES
TABLE 7 KEY OSTEOBIOLOGIC PRODUCTS AVAILABLE IN THE MARKET
TABLE 8 KEY SOFT TISSUE-MANAGEMENT PRODUCTS AVAILABLE IN THE MARKET
TABLE 9 NORTH AMERICA BIOSURGERY MARKET IN SOFT-TISSUE MANAGEMENT BY TYPES 2019-2027 (IN $ MILLION)
TABLE 10 KEY SURGICAL SEALING AGENTS AVAILABLE IN THE MARKET
TABLE 11 NORTH AMERICA BIOSURGERY MARKET IN SURGICAL SEALING AGENTS BY TYPES 2019-2027 (IN $ MILLION)
TABLE 12 NORTH AMERICA BIOSURGERY MARKET BY APPLICATIONS 2019-2027 (IN $ MILLION)
TABLE 13 TYPES OF CARDIOVASCULAR DISEASES
TABLE 14 STAGES OF GRAFT HEALING AND THEIR CHARACTERISTICS
TABLE 15 NORTH AMERICA BIOSURGERY MARKET BY SOURCE TYPE 2019-2027 (IN $ MILLION)
TABLE 16 NORTH AMERICA BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
TABLE 17 NORTH AMERICA BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)


FIGURES LIST
FIGURE 1 NORTH AMERICA BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
FIGURE 2 KEY STRATEGIES IN BIOSURGERY MARKET
FIGURE 3 U.S. PATENT ANALYSIS ON THE BASIS OF PRODUCT 2010-2016
FIGURE 4 U.S. PATENT ANALYSIS BY MARKET PARTICIPANT 2010-2016 (%)
FIGURE 5 DIFFERENT TYPES OF NATURAL BIOSURGICAL SEALANTS
FIGURE 6 NORTH AMERICA BIOSURGERY MARKET BY BONE-GRAFT SUBSTITUTES 2019-2027 (IN $ MILLION)
FIGURE 7 NORTH AMERICA BONE-GRAFT SUBSTITUTES MARKET BY SYNTHETIC GRAFT EXTENDERS 2019-2027 (IN $ MILLION)
FIGURE 8 NORTH AMERICA BONE-GRAFT SUBSTITUTES MARKET BY DEMINERALIZED BONE MATRIX 2019-2027 (IN $ MILLION)
FIGURE 9 NORTH AMERICA BONE-GRAFT SUBSTITUTES MARKET BY BONE MORPHOGENETIC PROTEINS 2019-2027 (IN $ MILLION)
FIGURE 10 NORTH AMERICA BONE-GRAFT SUBSTITUTES MARKET BY CELL-BASED MATRICES 2019-2027 (IN $ MILLION)
FIGURE 11 NORTH AMERICA BIOSURGERY MARKET BY HEMOSTATIC AGENTS 2019-2027 (IN $ MILLION)
FIGURE 12 NORTH AMERICA BIOSURGERY MARKET BY SOFT-TISSUE MANAGEMENT 2019-2027 (IN $ MILLION)
FIGURE 13 NORTH AMERICA BIOSURGERY MARKET IN SOFT-TISSUE MANAGEMENT 2019-2027 (IN $ MILLION)
FIGURE 14 NORTH AMERICA SOFT-TISSUE MANAGEMENT MARKET BY SYNTHETIC MESHES 2019-2027 (IN $ MILLION)
FIGURE 15 NORTH AMERICA BIOSURGERY MARKET BY SURGICAL SEALING AGENTS 2019-2027 (IN $ MILLION)
FIGURE 16 NORTH AMERICA BIOSURGERY MARKET BY NATURAL 2019-2027 (IN $ MILLION)
FIGURE 17 NORTH AMERICA BIOSURGERY MARKET BY SYNTHETIC 2019-2027 (IN $ MILLION)
FIGURE 18 NORTH AMERICA BIOSURGERY MARKET IN ANTI-ADHESIVE AGENTS 2019-2027 (IN $ MILLION)
FIGURE 19 NORTH AMERICA BIOSURGERY MARKET BY NEURO AND SPINE SURGERY 2019-2027 (IN $ MILLION)
FIGURE 20 NORTH AMERICA BIOSURGERY MARKET BY CARDIO AND THORACIC SURGERY 2019-2027 (IN $ MILLION)
FIGURE 21 NORTH AMERICA BIOSURGERY MARKET BY GENERAL SURGERY 2019-2027 (IN $ MILLION)
FIGURE 22 NORTH AMERICA BIOSURGERY MARKET BY ORTHOPEDIC SURGERY 2019-2027 (IN $ MILLION)
FIGURE 23 NORTH AMERICA BIOSURGERY MARKET BY NATURAL 2019-2027 (IN $ MILLION)
FIGURE 24 NORTH AMERICA BIOSURGERY MARKET BY SYNTHETIC 2019-2027 (IN $ MILLION)
FIGURE 25 NORTH AMERICA BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
FIGURE 26 THE UNITED STATES BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
FIGURE 27 DIABETES PREVALENCE AMONG DIFFERENT AMERICAN ETHNICITIES (%)
FIGURE 28 CANADA BIOSURGERY MARKET 2019-2027 (IN $ MILLION)